Abbvie Inc
NYSE:ABBV
Abbvie Inc
Accrued Liabilities
Abbvie Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accrued Liabilities
$7.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Amgen Inc
NASDAQ:AMGN
|
Accrued Liabilities
$15.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accrued Liabilities
$2.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
34%
|
CAGR 10-Years
25%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accrued Liabilities
$2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
25%
|
CAGR 10-Years
29%
|
|
Seagen Inc
NASDAQ:SGEN
|
Accrued Liabilities
$729.9m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|